Skip to main content
Erschienen in: European Surgery 1/2015

01.02.2015 | Original Article

Differences in quality of surgery for advanced gastric cancer between institutions

verfasst von: M. Ikeguchi, PhD, MD, M. Amisaki, MD, Y. Murakami, MD, T. Osaki, MD, H. Saito, MD

Erschienen in: European Surgery | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Summary

Background

Gastric cancer is one of the most common diseases in Japan, and surgery for gastric cancer is conducted in many general hospitals. However, there has been little investigation of the differences between institutions in terms of postoperative results in gastric cancer patients. This study aimed to compare the quality of treatment for gastric cancer between university hospital and general hospital.

Methods

We previously performed a multicenter trial in patients with stage II or III gastric cancer who underwent curative surgery followed by adjuvant S-1 chemotherapy. We selected 39 patients with similar backgrounds from this cohort: 16 from the Tottori University Hospital and 23 from a general hospital (Tottori Prefectural Central Hospital). Quality of surgery, postoperative patient nutrition and immunity, relapse-free survival, and overall survival were compared between the two groups.

Results

Operation time was significantly longer, but postoperative hospital stay was significantly shorter in the university group. Postoperative neutrophil/lymphocyte ratio and prognostic nutritional index improved significantly in the university group but remained unchanged in the general-hospital group. Relapse-free survival and overall survival both were better in the university group compared with the general-hospital group, although the difference in relapse-free survival was not significant.

Conclusions

Surgery and follow-up for advanced gastric cancer should be conducted by trained surgeons and gastric cancer specialists.
Literatur
1.
Zurück zum Zitat Sierzega M, Kolodziejczyk P, Kulig J, Polish Gastric Cancer Study Group. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg. 2010;97(7):1035–42.CrossRefPubMed Sierzega M, Kolodziejczyk P, Kulig J, Polish Gastric Cancer Study Group. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg. 2010;97(7):1035–42.CrossRefPubMed
2.
Zurück zum Zitat Kubota T, Hiki N, Sano T, et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol. 2014;21(3):891–8.CrossRefPubMed Kubota T, Hiki N, Sano T, et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol. 2014;21(3):891–8.CrossRefPubMed
3.
Zurück zum Zitat Relles DM, Burkhart RA, Pucci MJ, et al. Does resident experience affect outcomes in complex abdominal surgery? Pancreaticoduodenectomy as an example. J Gastrointest Surg. 2014;18(2):279–85.CrossRefPubMed Relles DM, Burkhart RA, Pucci MJ, et al. Does resident experience affect outcomes in complex abdominal surgery? Pancreaticoduodenectomy as an example. J Gastrointest Surg. 2014;18(2):279–85.CrossRefPubMed
4.
Zurück zum Zitat Lau K, Salami A, Barden G, et al. The effect of a regional hepatopancreaticobiliary surgical program on clinical volume, quality of cancer care, and outcomes in the veterans affairs system. JAMA Surg. 2014;149(11):1153–61. doi:10.1001/jamasurg.2014.1711.CrossRefPubMed Lau K, Salami A, Barden G, et al. The effect of a regional hepatopancreaticobiliary surgical program on clinical volume, quality of cancer care, and outcomes in the veterans affairs system. JAMA Surg. 2014;149(11):1153–61. doi:10.1001/jamasurg.2014.1711.CrossRefPubMed
5.
Zurück zum Zitat Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.CrossRefPubMed Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.CrossRefPubMed
6.
Zurück zum Zitat Tatebe S, Tsujitani S, Nakamura S, et al. Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial. Gastric Cancer. 2014;17:508–13.CrossRefPubMed Tatebe S, Tsujitani S, Nakamura S, et al. Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial. Gastric Cancer. 2014;17:508–13.CrossRefPubMed
7.
Zurück zum Zitat Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73:215–20.CrossRefPubMed Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73:215–20.CrossRefPubMed
8.
Zurück zum Zitat Ubkata H, Motohashi G, Tabuchi T, Nagata H, Konishi S, Tabuchi T. Evaluation of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol. 2010;102:742–7.CrossRef Ubkata H, Motohashi G, Tabuchi T, Nagata H, Konishi S, Tabuchi T. Evaluation of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol. 2010;102:742–7.CrossRef
9.
Zurück zum Zitat Nozoe T, Kohno M, Iguchi T, et al. The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today. 2012;42:532–5.CrossRefPubMed Nozoe T, Kohno M, Iguchi T, et al. The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today. 2012;42:532–5.CrossRefPubMed
10.
Zurück zum Zitat Maeda K, Shibutani M, Otani H, et al. Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor. World J Surg. 2014;38:1217–22.CrossRefPubMed Maeda K, Shibutani M, Otani H, et al. Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor. World J Surg. 2014;38:1217–22.CrossRefPubMed
11.
Zurück zum Zitat Yamada T, Hayashi T, Aoyama T, et al. Feasibility of enhanced recovery after surgery in gastric surgery: a retrospective study. BMC Surg. 2014;14:41. doi:10.1186/1471-2482-14–41.CrossRefPubMedCentralPubMed Yamada T, Hayashi T, Aoyama T, et al. Feasibility of enhanced recovery after surgery in gastric surgery: a retrospective study. BMC Surg. 2014;14:41. doi:10.1186/1471-2482-14–41.CrossRefPubMedCentralPubMed
12.
13.
Zurück zum Zitat Hsu PK, Chen HS, Wu SC, et al. Impact of hospital volume on long-term survival after resection for oesophageal cancer: a population-based study in Taiwan. Eur J Cardiothorac Surg. 2014;46(6):e127–35.CrossRefPubMed Hsu PK, Chen HS, Wu SC, et al. Impact of hospital volume on long-term survival after resection for oesophageal cancer: a population-based study in Taiwan. Eur J Cardiothorac Surg. 2014;46(6):e127–35.CrossRefPubMed
14.
Zurück zum Zitat Ravaioli M, Pinna AD, Francioni G, et al. A partnership model between high- and low-volume hospitals to improve results in hepatobiliary pancreatic surgery. Ann Surg. 2014;260(5):871–7.CrossRefPubMed Ravaioli M, Pinna AD, Francioni G, et al. A partnership model between high- and low-volume hospitals to improve results in hepatobiliary pancreatic surgery. Ann Surg. 2014;260(5):871–7.CrossRefPubMed
15.
Zurück zum Zitat Liu C, Lu Y, Jun Z, et al. Impact of total retrieved lymph nodes on staging and survival of patients with gastric cancer invading the subserosa. Surg Oncol. 2009;18(4):379–84.CrossRefPubMed Liu C, Lu Y, Jun Z, et al. Impact of total retrieved lymph nodes on staging and survival of patients with gastric cancer invading the subserosa. Surg Oncol. 2009;18(4):379–84.CrossRefPubMed
16.
Zurück zum Zitat Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Surgical treatment of advanced gastric cancer: Japanese perspective. Dig Surg. 2007;24:101–7.CrossRefPubMed Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Surgical treatment of advanced gastric cancer: Japanese perspective. Dig Surg. 2007;24:101–7.CrossRefPubMed
17.
Zurück zum Zitat Ligthart-Melis GC, Weijs PJ, te Boveldt ND, et al. Dietician-delivered intensive nutritional support is associated with a decrease in severe postoperative complications after surgery in patients with esophageal cancer. Dis Esophagus. 2013;26(6):587–93.CrossRefPubMed Ligthart-Melis GC, Weijs PJ, te Boveldt ND, et al. Dietician-delivered intensive nutritional support is associated with a decrease in severe postoperative complications after surgery in patients with esophageal cancer. Dis Esophagus. 2013;26(6):587–93.CrossRefPubMed
18.
Zurück zum Zitat Poulsen GM, Pedersen LL, Østerlind K, Bæksgaard L, Andersen JR. Randomized trial of the effects of individual nutritional counseling in cancer patients. Clin Nutr. 2014;33(5):749–53.CrossRefPubMed Poulsen GM, Pedersen LL, Østerlind K, Bæksgaard L, Andersen JR. Randomized trial of the effects of individual nutritional counseling in cancer patients. Clin Nutr. 2014;33(5):749–53.CrossRefPubMed
Metadaten
Titel
Differences in quality of surgery for advanced gastric cancer between institutions
verfasst von
M. Ikeguchi, PhD, MD
M. Amisaki, MD
Y. Murakami, MD
T. Osaki, MD
H. Saito, MD
Publikationsdatum
01.02.2015
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 1/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0295-y

Weitere Artikel der Ausgabe 1/2015

European Surgery 1/2015 Zur Ausgabe